Anti-melanoma differentiation-associated gene 5(MDA5) antibodies with amyopathic dermatomyositis (ADM) or clinical amyopathic dermatomyositis (CADM) are often complicated by rapidly progressive ILD (RP-ILD) (4). This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.